BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li CY, Li SC. Treatment of irritable bowel syndrome in China: A review. World J Gastroenterol 2015; 21(8): 2315-2322 [PMID: 25741137 DOI: 10.3748/wjg.v21.i8.2315]
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2315.htm
Number Citing Articles
1
Yeping Zhou, Dujuan Yang, Wenjun Gu, Weiguo Li. Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the ElderlyEmergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/6125120
2
T. M. Oliinyk, K. V. Rozova, O. I. Kovalchuk, T. Ya. Raskaliei, V. B. Raskaliei, Yu. K. Khmelnytska. THE PARTICIPATION OF HUMORAL MECHANISMS IN THE REGULATION OF THE CONTRACTILE ACTIVITY OF SMOOTH MUSCLE TISSUE OF THE INTESTINEBulletin of Problems Biology and Medicine 2023; 1(2): 42 doi: 10.29254/2077-4214-2023-4-171-42-47
3
Songhong Yang, Jinlian Zhang, Yiqi Yan, Ming Yang, Chao Li, Junmao Li, Lingyun Zhong, Qianfeng Gong, Huan Yu. Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Atractylodes macrocephala Koidz. for the Treatment of Chronic GastritisFrontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01629
4
Annie Tremblay, Xiaoyu Xu, James Colee, Thomas A. Tompkins, Sylvie Binda. Effectiveness of Medilac-S as an Adjuvant to Conventional Irritable Bowel Syndrome Treatments: A Systematic Review with Meta-AnalysisGastroenterology Insights 2023; 14(4): 491 doi: 10.3390/gastroent14040036
5
Senthilkumar Sankararaman, Sujithra Velayuthan, Youqin Chen, Jason Robertson, Thomas J. Sferra. Role of Traditional Chinese Herbal Medicines in Functional Gastrointestinal and Motility DisordersCurrent Gastroenterology Reports 2022; 24(3): 43 doi: 10.1007/s11894-022-00843-8
6
Jia-Jie Zhu, Shan Liu, Xiao-Lan Su, Zi-Song Wang, Yu Guo, Yi-Jie Li, Yang Yang, Li-Wei Hou, Qing-Guo Wang, Ru-Han Wei, Jian-Qin Yang, Wei Wei. Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled TrialsEvidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/4071260
7
Kok‐Ann Gwee, Uday Chand Ghoshal, Minhu Chen. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and managementJournal of Gastroenterology and Hepatology 2018; 33(1): 99 doi: 10.1111/jgh.13987
8
Di Qin, Ling Yue, Bin Xue, Min Chen, Tai-Chun Tang, Hui Zheng. Pharmacological treatments for patients with irritable bowel syndromeMedicine 2019; 98(32): e15920 doi: 10.1097/MD.0000000000015920
9
Stephen Birch, Myeong Soo Lee, Terje Alraek, Tae-Hun Kim. Overview of Treatment Guidelines and Clinical Practical Guidelines That Recommend the Use of Acupuncture: A Bibliometric AnalysisThe Journal of Alternative and Complementary Medicine 2018; 24(8): 752 doi: 10.1089/acm.2018.0092
10
Li‐Jiang Ji, Fang Li, Ping Zhao, Li‐Ping Weng, Jun  Wei, Jing Yan, Li‐Na Liu. Silencing interleukin 1α underlies a novel inhibitory role of miR‐181c‐5p in alleviating low‐grade inflammation of rats with irritable bowel syndromeJournal of Cellular Biochemistry 2019; 120(9): 15268 doi: 10.1002/jcb.28794
11
Yu-Tung Lai, Chung-Yu Chen, Ming-Jong Bair. Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in TaiwanFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.788795
12
Ye Gu, Yu-Tung Lai, Fang-Rong Chang, Chung-Yu Chen. Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in TaiwanFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201240
13
思颖 王. Research Progress on Gut Microbiota in the Treatment of Irritable Bowel SyndromeTraditional Chinese Medicine 2024; 13(01): 9 doi: 10.12677/TCM.2024.131002
14
Zhongyu Huang, Zhengkun Hou, Xianhua Liu, Fengbin Liu, Yuefeng Wu. Quantifying Liver Stagnation Spleen Deficiency Pattern for Diarrhea Predominate Irritable Bowel Syndromes Using Multidimensional Analysis MethodsEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/6467135
15
Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst, Amy C. Brown. Integrative Medicine2018; : 501 doi: 10.1016/B978-0-323-35868-2.00050-5
16
Chunhui Bao, Luyi Wu, Yin Shi, Zheng Shi, Xiaoming Jin, Jiacheng Shen, Jing Li, Zhihai Hu, Jianhua Chen, Xiaoqing Zeng, Wei Zhang, Zhe Ma, Zhijun Weng, Jinmei Li, Huirong Liu, Huangan Wu. Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trialTherapeutic Advances in Gastroenterology 2022; 15: 175628482210751 doi: 10.1177/17562848221075131
17
Guanqun Chao, Shuo Zhang. The characteristics of intestinal flora of IBS‐D with different syndromesImmunity, Inflammation and Disease 2020; 8(4): 615 doi: 10.1002/iid3.348
18
Weidong Wang, Fang Wang, Feng Fan, Ana Cristina Sedas, Jian Wang. Mind–Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-AnalysisInternational Journal of Behavioral Medicine 2017; 24(2): 191 doi: 10.1007/s12529-016-9589-0
19
Yoonjin Nam, Young Sil Min, Uy Dong Sohn. Recent advances in pharmacological research on the management of irritable bowel syndromeArchives of Pharmacal Research 2018; 41(10): 955 doi: 10.1007/s12272-018-1068-5
20
Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndromeJournal of Integrative Medicine 2021; 19(3): 274 doi: 10.1016/j.joim.2021.03.002
21
Chunhui Bao, Jingzhi Zhang, Jinmei Liu, Huirong Liu, Luyi Wu, Yin Shi, Jing Li, Zhihai Hu, Yongzheng Dong, Siyao Wang, Xiaoqing Zeng, Huangan Wu. Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trialBMC Complementary and Alternative Medicine 2016; 16(1) doi: 10.1186/s12906-016-1386-4
22
Jian-kui Wang, Juan Liu. Neuromuscular electrical stimulation as an adjunctive therapy to drotaverine hydrochloride for treating patients with diarrhea-predominant irritable bowel syndromeMedicine 2018; 97(29): e11478 doi: 10.1097/MD.0000000000011478